PEAK6 Investments »

Verve Therapeutics shares owned by PEAK6 Investments

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by PEAK6 Investments from 13F filings

Historical chart of PEAK6 Investments investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by PEAK6 Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by PEAK6 Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $266k 20k 13.28
2023-09-30 $240k 18k 13.26
2022-09-30 $288k 8.4k 34.29

More positions owned by PEAK6 Investments

NVIDIA Corporation Call Option (NVDA)
SPDR S&P 500 ETF TR Tr Unit Call Option (SPY)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Microstrategy Cl A New Call Option (MSTR)
Super Micro Computer Call Option (SMCI)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Advanced Micro Devices Call Option (AMD)
Qualcomm Call Option (QCOM)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for PEAK6 Investments

Top funds holding Verve Therapeutics

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Millennium Management
FMR
State Street Corporation
Casdin Capital
ARK Investment Management
Novo A/S
Arch Venture Corp
Baker Bros. Advisors
Jpmorgan Chase & Co
Geode Capital Management
Redmile Group

View all funds holding Verve Therapeutics